Centro Hospitalar Tondela Viseu, Portugal.
Hospital Pedro Hispano, Matosinhos, Portugal.
J Bras Nefrol. 2024 Jan-Mar;46(1):93-97. doi: 10.1590/2175-8239-JBN-2023-0015en.
End of life care of patients with end-stage kidney disease (ESKD) may be particularly challenging and requires the intervention of a specialized palliative care team (PCT).
To characterize the population of ESKD patients referred to a PCT and evaluate the determinants of planned dying at home.
We performed a retrospective observational cohort study of all patients with ESKD referred to our PCT between January 2014 and December 2021 (n = 60) and further characterized those with previously known ESKD regarding place of death (n = 53).
The majority of the patients were female and the median age was 84 years. Half of the patients were on conservative treatment, 43% were on chronic hemodialysis, and the remainder underwent hemodialysis on a trial basis and were subsequently suspended. Of those with previously known ESKD, 18% died at home and neither gender, age, cognition, performance status, comorbidities, CKD etiology, or treatment modality were associated with place of death. Anuria was significantly associated with dying at the hospital as was shorter time from dialysis suspension and death. Although not reaching statistical significance, we found a tendency towards a longer duration of palliative care follow-up in those dying at home.
Dying at home is possible in a palliative domiciliary program regardless of age, gender, etiology of CKD, major comorbidities, and treatment modality. Anuria and shorter survival from RRT withdrawal may be limiting factors for planned dying at home. A longer follow-up by palliative care may favor dying at home.
终末期肾病(ESKD)患者的临终关怀可能特别具有挑战性,需要专门的姑息治疗团队(PCT)的干预。
描述转介至 PCT 的 ESKD 患者人群,并评估计划在家中死亡的决定因素。
我们对 2014 年 1 月至 2021 年 12 月期间所有转介至我们的 PCT 的 ESKD 患者(n = 60)进行了回顾性观察队列研究,并进一步对先前已知的 ESKD 患者的死亡地点进行了特征描述(n = 53)。
大多数患者为女性,中位年龄为 84 岁。一半的患者接受保守治疗,43%的患者接受慢性血液透析,其余患者接受血液透析试验,随后暂停。在先前已知的 ESKD 患者中,18%在家中死亡,性别、年龄、认知、表现状态、合并症、CKD 病因或治疗方式均与死亡地点无关。无尿与在医院死亡显著相关,透析暂停与死亡之间的时间也较短。尽管没有达到统计学意义,但我们发现,在家中死亡的患者接受姑息治疗的随访时间更长。
在姑息家庭护理计划中,无论年龄、性别、CKD 病因、主要合并症和治疗方式如何,在家中死亡都是可能的。无尿和 RRT 撤停后的生存时间较短可能是计划在家中死亡的限制因素。姑息治疗的随访时间更长可能有利于在家中死亡。